PRR - CVAC DEMONSTRATES IMPROVEMENT IN PROGRESSION FREE SURVIVAL IN SECOND REMISSION OVARIAN CANCER
? Final PFS data from CAN-003 trial of CVac indicate stronger trends toward improvement in second remission ovarian cancer patients than previous top-line data
? Validates objectives of recently launched 210-patient, phase 2, CAN-004-B trial ? Dr. Heidi Gray to deliver oral presentation (Abstract #5504) at ASCO Annual Meeting
